---
title: "12 Health Care Stocks Moving In Friday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292366801.md"
description: "During Friday's after-market session, several healthcare stocks experienced significant volatility. Q32 Bio surged 44.4% to $16.19, while China Pharma Holding rose 13.15%. Other gainers included Conmed, Aardvark Therapeutics, Eledon Pharmaceuticals, and Accuray. Conversely, Med Pharmaceuticals fell 7.9%, with declines also seen in Atea Pharmaceuticals, Gelteq, OKYO Pharma, Universe Pharmaceuticals, and Galmed Pharmaceuticals."
datetime: "2026-07-10T21:05:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292366801.md)
  - [en](https://longbridge.com/en/news/292366801.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292366801.md)
---

# 12 Health Care Stocks Moving In Friday's After-Market Session

### Gainers

-   **Q32 Bio** (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-market session. The company's market cap stands at $213.4 million.
-   **China Pharma Holding** (AMEX:CPHI) shares increased by 13.15% to $0.65. The market value of their outstanding shares is at $25.9 million.
-   **Conmed** (NYSE:CNMD) shares increased by 8.88% to $41.9. The market value of their outstanding shares is at $1.1 billion.
-   **Aardvark Therapeutics** (NASDAQ:AARD) shares increased by 8.79% to $8.27. The market value of their outstanding shares is at $109.0 million.
-   **Eledon Pharmaceuticals** (NASDAQ:ELDN) shares moved upwards by 5.23% to $4.05. The company's market cap stands at $318.7 million.
-   **Accuray** (NASDAQ:ARAY) shares moved upwards by 4.8% to $0.25. The company's market cap stands at $31.4 million.

### Losers

-   **InMed Pharmaceuticals** (NASDAQ:INM) shares fell 7.9% to $1.51 during Friday's after-market session. The company's market cap stands at $8.8 million.
-   **Atea Pharmaceuticals** (NASDAQ:AVIR) stock fell 6.81% to $4.65. The company's market cap stands at $392.9 million.
-   **Gelteq** (NASDAQ:GELS) shares decreased by 6.06% to $0.5. The market value of their outstanding shares is at $5.8 million.
-   **OKYO Pharma** (NASDAQ:OKYO) stock decreased by 5.33% to $1.6. The company's market cap stands at $88.1 million.
-   **Universe Pharmaceuticals** (NASDAQ:UPC) shares decreased by 5.32% to $4.99. The company's market cap stands at $3.4 million.
-   **Galmed Pharmaceuticals** (NASDAQ:GLMD) shares decreased by 5.02% to $0.53. The company's market cap stands at $4.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [OKYO.US](https://longbridge.com/en/quote/OKYO.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [AARD.US](https://longbridge.com/en/quote/AARD.US.md)
- [GELS.US](https://longbridge.com/en/quote/GELS.US.md)
- [QTTB.US](https://longbridge.com/en/quote/QTTB.US.md)
- [ELDN.US](https://longbridge.com/en/quote/ELDN.US.md)
- [AVIR.US](https://longbridge.com/en/quote/AVIR.US.md)
- [ARAY.US](https://longbridge.com/en/quote/ARAY.US.md)
- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [CNMD.US](https://longbridge.com/en/quote/CNMD.US.md)
- [GLMD.US](https://longbridge.com/en/quote/GLMD.US.md)
- [INM.US](https://longbridge.com/en/quote/INM.US.md)

## Related News & Research

- [CONMED Q2 FY26 adjusted EPS rises 20% to $1.38; net sales increase 0.3% to $343.5 million](https://longbridge.com/en/news/294256433.md)
- [Conmed Q2 sales, adjusted profit beat on organinc platform growth](https://longbridge.com/en/news/294257535.md)
- [Q32 Bio Inc. (NASDAQ:QTTB) Sees Large Increase in Short Interest](https://longbridge.com/en/news/293861610.md)
- [Atea says Phase 3 C-BEYOND trial shows hepatitis C combo bemnifosbuvir/ruzasvir matches Epclusa on cure rates](https://longbridge.com/en/news/294054672.md)
- [OKYO Pharma joins BTIG Biotechnology Conference 2026](https://longbridge.com/en/news/293920619.md)